Latest filing published 17 Oct 2025 for Keros Therapeutics, Inc., €17.1M.
Filing timeline
BuySaleInsider track record
Closed purchases
Based on 5 purchases whose 90-day window has closed (published at least 91 days ago), the same population our ranking model reads.
Purchases by company
Since each purchase
- +158.4%Entry US$16.31 · Close at T+365 US$42.14
- +123.6%Entry US$27.49 · Close at T+365 US$61.47
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
Pontifax Management 4 G.P. (2015) Ltd.: trading record in brief
Pontifax Management 4 G.P. (2015) Ltd. has filed trades across 3 companies (mainly through SEC (Form 4)), most often in Keros Therapeutics, Inc., Eloxx Pharmaceuticals, Inc. and LB Pharmaceuticals Inc. Over a trading history stretching from 21 March 2018 to 15 October 2025, the count stands at 45 filings.
The open-market side counts 26 purchases for €32.8M alongside 4 sales for €73.0M. Netting one side against the other leaves €40.1M of net selling. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay. Outside the open market, there are 3 share grants. 2025 to date brings 1 purchase and 4 sales.
A typical purchase (the median) is worth €652k. On 26 out of 26 purchases, another insider of the same company was buying within the same 30 days. A cluster is several different insiders buying the same stock within a short window, a pattern studied more closely than a single purchase. Looking at 5 purchases old enough to measure, the stock rose over the following 90 days in 100% of cases; the median change was +12.0%. These figures describe past trades and do not predict future prices.
On 17 October 2025 came the latest disclosure, an open-market sale for €17.1M in Keros Therapeutics, Inc. The last purchase on record was published on 16 September 2025, which is 418 days ago. Filings reach the SEC (Form 4) feed a median of 1 day after the trade. Section 16 rules allow two business days to file each Form 4. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Companies and markets linked to Pontifax Management 4 G.P. (2015) Ltd.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 1,121,045 shares@ US$17.7520.9% of flowCommon Stock, $0.0001 par value per shareSEC:0000921895-25-002765:1
- 1,226,412 shares@ US$17.7522.8% of flowCommon Stock, $0.0001 par value per shareSEC:0000921895-25-002765:2
- 155,262 shares@ US$17.752.9% of flowCommon Stock, $0.0001 par value per shareSEC:0000921895-25-002765:3
- 2,284,612 shares@ US$17.75100.0% of flowCommon Stock, $0.0001 par value per shareSEC:0000921895-25-002765:0
- 1,000,000 shares@ US$15.00100.0% of flowCommon StockSEC:0001726334-25-000003:1Canonical exit: 11 Dec 2025 (T+90)
- 411,681 sharesCommon StockSEC:0001726334-25-000003:0
- 1,723 sharesCommon StockSEC:0001209191-22-059053:1
- 1,914 sharesCommon StockSEC:0001209191-22-059053:2
- 3,539 shares0.0% of flowCommon StockSEC:0001209191-22-059053:0
- 2,630,487 shares@ US$1.3530.4% of flowCommon StockSEC:0001104659-21-067336:1Canonical exit: 11 Aug 2021 (T+90)
- 1,422,222 shares@ US$1.3516.4% of flowCommon StockSEC:0001104659-21-067336:2Canonical exit: 11 Aug 2021 (T+90)
- 592,592 shares@ US$1.356.8% of flowCommon StockSEC:0001104659-21-067336:3Canonical exit: 11 Aug 2021 (T+90)
- ▲
Same trade as the filing by Ran Nussbaum, counted once
2M USD28SEC1,280,624 shares@ US$1.35100.0% of flowCommon StockSEC:0001104659-21-067336:0Canonical exit: 11 Aug 2021 (T+90) - ▲
Same trade as the filing by Tomer Kariv, counted once
1M USD26SEC26,634 shares@ US$50.002.6% of flowCommon StockSEC:0001209191-20-059404:0Canonical exit: 15 Feb 2021 (T+90) - ▲
Same trade as the filing by Tomer Kariv, counted once
648,300 USD26SEC12,966 shares@ US$50.001.2% of flowCommon StockSEC:0001209191-20-059404:1Canonical exit: 15 Feb 2021 (T+90) - ▲
Same trade as the filing by Tomer Kariv, counted once
720,000 USD26SEC14,400 shares@ US$50.001.4% of flowCommon StockSEC:0001209191-20-059404:2Canonical exit: 15 Feb 2021 (T+90) - ▲
Same trade as the filing by Tomer Kariv, counted once
300,000 USD26SEC6,000 shares@ US$50.000.6% of flowCommon StockSEC:0001209191-20-059404:3Canonical exit: 15 Feb 2021 (T+90) - 663,825 sharesCommon StockSEC:0001209191-20-024231:1
- 737,226 sharesCommon StockSEC:0001209191-20-024231:2
- 169,307 sharesCommon StockSEC:0001209191-20-024231:3
- 82,425 sharesCommon StockSEC:0001209191-20-024231:4
- 91,538 sharesCommon StockSEC:0001209191-20-024231:5
- 68,654 sharesCommon StockSEC:0001209191-20-024231:6
- 163,612 sharesCommon StockSEC:0001209191-20-024231:7
- 88,460 sharesCommon StockSEC:0001209191-20-024231:8
25 of 40 declarations
